Australia · Delayed Price · Currency is AUD Challenger Earnings Call Transcripts
Fiscal Year 2026
-
The business is leveraging demographic and regulatory tailwinds to scale retirement income solutions, driven by technology, partnerships, and capital reforms. Enhanced capital efficiency, digital transformation, and new offshore reinsurance capabilities position it for sustained growth and improved shareholder returns.
-
H1 2026 saw earnings and returns above target, record annuity sales, and strong capital management, with an increased dividend and a planned AUD 150 million buyback. Strategic partnerships, technology upgrades, and offshore expansion position the business for continued growth.
Fiscal Year 2025
-
APRA's proposed capital standards for longevity products will make capital requirements more risk-sensitive, reduce volatility, and release excess capital, enabling growth and innovation in retirement solutions. The business anticipates a shift to higher-quality fixed income assets and expects improved resilience, lower capital intensity, and enhanced shareholder returns.
-
Celebrating 40 years, the meeting highlighted strong financial results, board renewal, and a focus on digital transformation and sustainability. Shareholders approved all resolutions, and optimism was expressed for future growth amid regulatory reforms and evolving market conditions.
-
FY 2025 delivered 9% growth in earnings and EPS, with ROE above target and a record dividend increase. Strategic partnerships, product innovation, and digital transformation position the business for sustainable growth, while APRA capital reforms are expected to further enhance flexibility and returns.
-
Strong 1H25 results featured double-digit earnings growth, record annuity sales, and ROE above target, supported by cost discipline and strategic investments in technology. The business remains on track to meet FY25 guidance, with a robust capital position and continued momentum in life and funds management.
Fiscal Year 2024
-
The meeting reviewed strong financial results, with profit and assets under management both rising significantly. Board composition was refreshed, dividends increased, and progress made on ESG and diversity. Strategic investments in technology and partnerships were highlighted, with all director elections and resolutions supported.
-
Delivered strong FY 2024 results with 17% growth in normalized pre-tax profit and 21% AUM increase, driven by longer-duration Life sales and cost discipline. ROE rose to 15.6%, and guidance for FY 2025 targets further profit and efficiency gains.